Home > PS Ratio > CONCORD DRUGS

CONCORD DRUGS
PS (Price/Sales) Ratio

The Current P/S Ratio of CONCORD DRUGS is 1.15.

Share Price ₹74.9Aug 11,2026
Market Cap ₹98.9 Cr
Sales-TTM₹86.1 CrTTM-Consolidated Results
Price/Sales1.15xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for CONCORD DRUGS
Please provide your vote to see the results
CONCORD DRUGS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of CONCORD DRUGS

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of CONCORD DRUGS is calculated as :

Current Market Cap [ ₹98.9 Cr] as on Aug 11,2026

(/) Sales [ ₹86.1 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 1.15x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for CONCORD DRUGS , the investors are currently willing to pay '1.15 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of CONCORD DRUGS !

The chart below summarizes the trend in P/S Ratio of CONCORD DRUGS over the last five years.

Historical PS (Price/Sales) ratio chart of CONCORD DRUGS


PS Ratio Performance Analysis for CONCORD DRUGS

- CONCORD DRUGS 's latest p/e ratio is 1.15x.

- CONCORD DRUGS 's p/e ratio for fiscal years ending Mar2025 to Mar2022 averaged 0.60x.

- CONCORD DRUGS 's operated at median p/e ratio of 0.69x from fiscal years ending March 2018 to 2022.

- Looking back at the last 4 fiscal years, CONCORD DRUGS 's p/e ratio peaked in Mar2024 at 0.78x.

- CONCORD DRUGS 's p/e ratio hit its five-year low in Mar2022 of 0.43x.


How does CONCORD DRUGS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
CONCORD DRUGS 86.11.1598.9
SUN PHARMACEUTICAL INDUSTRIES LTD59,910.57.77465,471.0
DIVIS LABORATORIES LTD11,230.020.18226,631.0
TORRENT PHARMACEUTICALS LTD15,723.011.78185,157.0
CIPLA LTD28,324.44.17118,108.0
DR REDDYS LABORATORIES LTD33,227.93.03100,578.0
MANKIND PHARMA LTD14,737.96.80100,152.0
LUPIN LTD29,966.63.48104,158.0
ZYDUS LIFESCIENCES LTD28,591.74.12117,705.0
AUROBINDO PHARMA LTD34,935.32.7094,477.0
LAURUS LABS LTD7,269.613.82100,498.0

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs CONCORD DRUGS 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 1.15x
Max industry PS 20.18x
Median industry PS 4.17x
Average industry PS 7.18x



You may also like the below Video Courses